_id
6915fe9dbc934aba376b2870
Ticker
SRRK
Name
Scholar Rock Holding Corp
Exchange
NASDAQ
Address
301 Binney Street, Cambridge, MA, United States, 02142
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.scholarrock.com
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Last Close
46.83
Volume
2009154
Current Price
46.87
Change
0.08541533205210154
Last Updated
2025-12-04T13:31:37.936Z
Image
data:image/webp;base64,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
Ipo Date
2018-05-24T00:00:00.000Z
Market Cap
4438344192
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8449846153846153
Sentiment Sources
13
Rating
4.6
Target Price
47.3333
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
423000
Gross Profit
-423000
Operating Expenses
103127000
Operating Income
-103550000
Interest Expense
1334000
Pretax Income
-102220000
Net Income
-102220000
Eps
-0.8987965780311853
Dividends Per Share
-
Shares Outstanding
102007457
Income Tax Expense
-
EBITDA
-100463000
Operating Margin
-
Total Other Income Expense Net
1330000
Cash
286770000
Short Term Investments
82860000
Receivables
3549000
Inventories
-
Total Current Assets
390711000
Property Plant Equipment
13883000
Total Assets
411718000
Payables
6765000
Short Term Debt
5325000
Long Term Debt
99611000
Total Liabilities
166723000
Equity
244995000
Depreciation
423000
Change In Working Capital
17542000
Cash From Operations
-68923000
Capital Expenditures
84000
Cash From Investing
59699000
Cash From Financing
144469000
Net Change In Cash
135245000
PE
-
PB
21.757660644094774
ROE
-41.723300475519906
ROA
-24.82767331037263
FCF
-69007000
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
423000
Quarters > 0 > income Statement > gross Profit
-423000
Quarters > 0 > income Statement > operating Expenses
103127000
Quarters > 0 > income Statement > operating Income
-103550000
Quarters > 0 > income Statement > interest Expense
1334000
Quarters > 0 > income Statement > pretax Income
-102220000
Quarters > 0 > income Statement > net Income
-102220000
Quarters > 0 > income Statement > eps
-0.8987965780311853
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
113729850
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-100463000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1330000
Quarters > 0 > balance Sheet > cash
286770000
Quarters > 0 > balance Sheet > short Term Investments
82860000
Quarters > 0 > balance Sheet > receivables
3549000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
390711000
Quarters > 0 > balance Sheet > property Plant Equipment
13883000
Quarters > 0 > balance Sheet > total Assets
411718000
Quarters > 0 > balance Sheet > payables
6765000
Quarters > 0 > balance Sheet > short Term Debt
5325000
Quarters > 0 > balance Sheet > long Term Debt
99611000
Quarters > 0 > balance Sheet > total Liabilities
166723000
Quarters > 0 > balance Sheet > equity
244995000
Quarters > 0 > cash Flow > net Income
-102220000
Quarters > 0 > cash Flow > depreciation
423000
Quarters > 0 > cash Flow > change In Working Capital
17542000
Quarters > 0 > cash Flow > cash From Operations
-68923000
Quarters > 0 > cash Flow > capital Expenditures
84000
Quarters > 0 > cash Flow > cash From Investing
59699000
Quarters > 0 > cash Flow > cash From Financing
144469000
Quarters > 0 > cash Flow > net Change In Cash
135245000
Quarters > 0 > ratios > PE
-0.8987965780311853
Quarters > 0 > ratios > PB
21.757660644094774
Quarters > 0 > ratios > ROE
-41.723300475519906
Quarters > 0 > ratios > ROA
-24.82767331037263
Quarters > 0 > ratios > FCF
-69007000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
417000
Quarters > 1 > income Statement > gross Profit
-417000
Quarters > 1 > income Statement > operating Expenses
111692000
Quarters > 1 > income Statement > operating Income
-112109000
Quarters > 1 > income Statement > interest Expense
1206000
Quarters > 1 > income Statement > pretax Income
-110031000
Quarters > 1 > income Statement > net Income
-110031000
Quarters > 1 > income Statement > eps
-0.9762915479793646
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
112703014
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-108408000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2078000
Quarters > 1 > balance Sheet > cash
152925000
Quarters > 1 > balance Sheet > short Term Investments
142088000
Quarters > 1 > balance Sheet > receivables
1968000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
319126000
Quarters > 1 > balance Sheet > property Plant Equipment
15548000
Quarters > 1 > balance Sheet > total Assets
340045000
Quarters > 1 > balance Sheet > payables
1104000
Quarters > 1 > balance Sheet > short Term Debt
5212000
Quarters > 1 > balance Sheet > long Term Debt
49756000
Quarters > 1 > balance Sheet > total Liabilities
106752000
Quarters > 1 > balance Sheet > equity
233293000
Quarters > 1 > cash Flow > net Income
-110031000
Quarters > 1 > cash Flow > depreciation
417000
Quarters > 1 > cash Flow > change In Working Capital
8325000
Quarters > 1 > cash Flow > cash From Operations
-76941000
Quarters > 1 > cash Flow > capital Expenditures
215000
Quarters > 1 > cash Flow > cash From Investing
85466000
Quarters > 1 > cash Flow > cash From Financing
6474000
Quarters > 1 > cash Flow > net Change In Cash
14999000
Quarters > 1 > ratios > PE
-0.9762915479793646
Quarters > 1 > ratios > PB
22.64272938399352
Quarters > 1 > ratios > ROE
-47.164295542515205
Quarters > 1 > ratios > ROA
-32.35777617668249
Quarters > 1 > ratios > FCF
-77156000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
393000
Quarters > 2 > income Statement > gross Profit
-393000
Quarters > 2 > income Statement > operating Expenses
76697000
Quarters > 2 > income Statement > operating Income
-77090000
Quarters > 2 > income Statement > interest Expense
1818000
Quarters > 2 > income Statement > pretax Income
-74723000
Quarters > 2 > income Statement > net Income
-74723000
Quarters > 2 > income Statement > eps
-0.6681360539351562
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
111838000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-76697000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2367000
Quarters > 2 > balance Sheet > cash
137926000
Quarters > 2 > balance Sheet > short Term Investments
226449000
Quarters > 2 > balance Sheet > receivables
1944000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
385247000
Quarters > 2 > balance Sheet > property Plant Equipment
17042000
Quarters > 2 > balance Sheet > total Assets
407553000
Quarters > 2 > balance Sheet > payables
4437000
Quarters > 2 > balance Sheet > short Term Debt
5497000
Quarters > 2 > balance Sheet > long Term Debt
49741000
Quarters > 2 > balance Sheet > total Liabilities
95220000
Quarters > 2 > balance Sheet > equity
312333000
Quarters > 2 > cash Flow > net Income
-74723000
Quarters > 2 > cash Flow > depreciation
393000
Quarters > 2 > cash Flow > change In Working Capital
-17542000
Quarters > 2 > cash Flow > cash From Operations
-78675000
Quarters > 2 > cash Flow > capital Expenditures
271000
Quarters > 2 > cash Flow > cash From Investing
34554000
Quarters > 2 > cash Flow > cash From Financing
4168999
Quarters > 2 > cash Flow > net Change In Cash
-39952000
Quarters > 2 > ratios > PE
-0.6681360539351562
Quarters > 2 > ratios > PB
16.782879362731443
Quarters > 2 > ratios > ROE
-23.92414506312173
Quarters > 2 > ratios > ROA
-18.334547899291625
Quarters > 2 > ratios > FCF
-78946000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
395000
Quarters > 3 > income Statement > gross Profit
-395000
Quarters > 3 > income Statement > operating Expenses
68962000
Quarters > 3 > income Statement > operating Income
-69357000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-66453999
Quarters > 3 > income Statement > net Income
-66453999
Quarters > 3 > income Statement > eps
-0.6656182916324446
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
99838000
Quarters > 3 > income Statement > income Tax Expense
-555000
Quarters > 3 > income Statement > EBITDA
-66059000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2903000
Quarters > 3 > balance Sheet > cash
177878000
Quarters > 3 > balance Sheet > short Term Investments
259400000
Quarters > 3 > balance Sheet > receivables
2151000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
451165000
Quarters > 3 > balance Sheet > property Plant Equipment
18405000
Quarters > 3 > balance Sheet > total Assets
474922000
Quarters > 3 > balance Sheet > payables
10095000
Quarters > 3 > balance Sheet > short Term Debt
5774000
Quarters > 3 > balance Sheet > long Term Debt
50146000
Quarters > 3 > balance Sheet > total Liabilities
106288000
Quarters > 3 > balance Sheet > equity
368634000
Quarters > 3 > cash Flow > net Income
-66454000
Quarters > 3 > cash Flow > depreciation
395000
Quarters > 3 > cash Flow > change In Working Capital
7153000
Quarters > 3 > cash Flow > cash From Operations
-49513000
Quarters > 3 > cash Flow > capital Expenditures
22000
Quarters > 3 > cash Flow > cash From Investing
-195370000
Quarters > 3 > cash Flow > cash From Financing
346370000
Quarters > 3 > cash Flow > net Change In Cash
101487000
Quarters > 3 > ratios > PE
-0.6656182916324446
Quarters > 3 > ratios > PB
12.693910653927743
Quarters > 3 > ratios > ROE
-18.02709435374925
Quarters > 3 > ratios > ROA
-13.992613313344085
Quarters > 3 > ratios > FCF
-49535000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1937000
Annuals > 0 > income Statement > gross Profit
-1937000
Annuals > 0 > income Statement > operating Expenses
250117000
Annuals > 0 > income Statement > operating Income
-252054000
Annuals > 0 > income Statement > interest Expense
6837000
Annuals > 0 > income Statement > pretax Income
-246294000
Annuals > 0 > income Statement > net Income
-246294000
Annuals > 0 > income Statement > eps
-2.4669364370279854
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
99838000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-237520000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
5760000
Annuals > 0 > balance Sheet > cash
177878000
Annuals > 0 > balance Sheet > short Term Investments
259400000
Annuals > 0 > balance Sheet > receivables
2151000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
451165000
Annuals > 0 > balance Sheet > property Plant Equipment
18405000
Annuals > 0 > balance Sheet > total Assets
474922000
Annuals > 0 > balance Sheet > payables
10095000
Annuals > 0 > balance Sheet > short Term Debt
5774000
Annuals > 0 > balance Sheet > long Term Debt
50146000
Annuals > 0 > balance Sheet > total Liabilities
106288000
Annuals > 0 > balance Sheet > equity
368634000
Annuals > 0 > cash Flow > net Income
-246294000
Annuals > 0 > cash Flow > depreciation
1937000
Annuals > 0 > cash Flow > change In Working Capital
6594000
Annuals > 0 > cash Flow > cash From Operations
-200949000
Annuals > 0 > cash Flow > capital Expenditures
98000
Annuals > 0 > cash Flow > cash From Investing
-76056000
Annuals > 0 > cash Flow > cash From Financing
353028000
Annuals > 0 > cash Flow > net Change In Cash
76023000
Annuals > 0 > ratios > PE
-2.4669364370279854
Annuals > 0 > ratios > PB
11.783914071952125
Annuals > 0 > ratios > ROE
-66.81261088233857
Annuals > 0 > ratios > ROA
-51.85988435995805
Annuals > 0 > ratios > FCF
-201047000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
2844000
Annuals > 1 > income Statement > gross Profit
-2844000
Annuals > 1 > income Statement > operating Expenses
168451000
Annuals > 1 > income Statement > operating Income
-171295000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-165789000
Annuals > 1 > income Statement > net Income
-165789000
Annuals > 1 > income Statement > eps
-2.1820371418418247
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
75979000
Annuals > 1 > income Statement > income Tax Expense
2676105
Annuals > 1 > income Statement > EBITDA
-162945000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5506000
Annuals > 1 > balance Sheet > cash
101855000
Annuals > 1 > balance Sheet > short Term Investments
178083000
Annuals > 1 > balance Sheet > receivables
1076000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
288194000
Annuals > 1 > balance Sheet > property Plant Equipment
16017000
Annuals > 1 > balance Sheet > total Assets
311035000
Annuals > 1 > balance Sheet > payables
3465000
Annuals > 1 > balance Sheet > short Term Debt
8742000
Annuals > 1 > balance Sheet > long Term Debt
48684000
Annuals > 1 > balance Sheet > total Liabilities
85817000
Annuals > 1 > balance Sheet > equity
225218000
Annuals > 1 > cash Flow > net Income
-165789000
Annuals > 1 > cash Flow > depreciation
2844000
Annuals > 1 > cash Flow > change In Working Capital
-10614000
Annuals > 1 > cash Flow > cash From Operations
-145226000
Annuals > 1 > cash Flow > capital Expenditures
71000
Annuals > 1 > cash Flow > cash From Investing
41141000
Annuals > 1 > cash Flow > cash From Financing
102574000
Annuals > 1 > cash Flow > net Change In Cash
-1511000
Annuals > 1 > ratios > PE
-2.1820371418418247
Annuals > 1 > ratios > PB
14.678428411583443
Annuals > 1 > ratios > ROE
-73.61267749469404
Annuals > 1 > ratios > ROA
-53.302361470574056
Annuals > 1 > ratios > FCF
-145297000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
33193000
Annuals > 2 > income Statement > cost Of Revenue
9885000
Annuals > 2 > income Statement > gross Profit
33193000
Annuals > 2 > income Statement > operating Expenses
167563000
Annuals > 2 > income Statement > operating Income
-134370000
Annuals > 2 > income Statement > interest Expense
2854000
Annuals > 2 > income Statement > pretax Income
-134502000
Annuals > 2 > income Statement > net Income
-131648000
Annuals > 2 > income Statement > eps
-2.208427157266022
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
59611656
Annuals > 2 > income Statement > income Tax Expense
-2854000
Annuals > 2 > income Statement > EBITDA
-131384000
Annuals > 2 > income Statement > operating Margin
-404.8142680685687
Annuals > 2 > income Statement > total Other Income Expense Net
-132000
Annuals > 2 > balance Sheet > cash
103275000
Annuals > 2 > balance Sheet > short Term Investments
212086000
Annuals > 2 > balance Sheet > receivables
2735000
Annuals > 2 > balance Sheet > inventories
-2735000
Annuals > 2 > balance Sheet > total Current Assets
328024000
Annuals > 2 > balance Sheet > property Plant Equipment
25927000
Annuals > 2 > balance Sheet > total Assets
358168000
Annuals > 2 > balance Sheet > payables
3994000
Annuals > 2 > balance Sheet > short Term Debt
7852000
Annuals > 2 > balance Sheet > long Term Debt
49744000
Annuals > 2 > balance Sheet > total Liabilities
97933000
Annuals > 2 > balance Sheet > equity
260235000
Annuals > 2 > cash Flow > net Income
-134502000
Annuals > 2 > cash Flow > depreciation
2986000
Annuals > 2 > cash Flow > change In Working Capital
-34389000
Annuals > 2 > cash Flow > cash From Operations
-132694000
Annuals > 2 > cash Flow > capital Expenditures
1064000
Annuals > 2 > cash Flow > cash From Investing
-171698000
Annuals > 2 > cash Flow > cash From Financing
194832000
Annuals > 2 > cash Flow > net Change In Cash
-109560000
Annuals > 2 > ratios > PE
-2.208427157266022
Annuals > 2 > ratios > PB
9.966772926624012
Annuals > 2 > ratios > ROE
-50.58812227409841
Annuals > 2 > ratios > ROA
-36.75593576198879
Annuals > 2 > ratios > FCF
-133758000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-4.0297050582954235
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
18816000
Annuals > 3 > income Statement > cost Of Revenue
108468000
Annuals > 3 > income Statement > gross Profit
-89652000
Annuals > 3 > income Statement > operating Expenses
40268000
Annuals > 3 > income Statement > operating Income
-129920000
Annuals > 3 > income Statement > interest Expense
1878000
Annuals > 3 > income Statement > pretax Income
-131799000
Annuals > 3 > income Statement > net Income
-131799000
Annuals > 3 > income Statement > eps
-3.5900958690894025
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
36711833
Annuals > 3 > income Statement > income Tax Expense
2390442
Annuals > 3 > income Statement > EBITDA
-127294000
Annuals > 3 > income Statement > operating Margin
-690.4761904761905
Annuals > 3 > income Statement > total Other Income Expense Net
-1879000
Annuals > 3 > balance Sheet > cash
212835000
Annuals > 3 > balance Sheet > short Term Investments
40159000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
265319000
Annuals > 3 > balance Sheet > property Plant Equipment
35006000
Annuals > 3 > balance Sheet > total Assets
304445000
Annuals > 3 > balance Sheet > payables
4434000
Annuals > 3 > balance Sheet > short Term Debt
16391000
Annuals > 3 > balance Sheet > long Term Debt
48422000
Annuals > 3 > balance Sheet > total Liabilities
132371000
Annuals > 3 > balance Sheet > equity
172074000
Annuals > 3 > cash Flow > net Income
-131799000
Annuals > 3 > cash Flow > depreciation
2627000
Annuals > 3 > cash Flow > change In Working Capital
-28440000
Annuals > 3 > cash Flow > cash From Operations
-126789000
Annuals > 3 > cash Flow > capital Expenditures
5248000
Annuals > 3 > cash Flow > cash From Investing
134315000
Annuals > 3 > cash Flow > cash From Financing
44951000
Annuals > 3 > cash Flow > net Change In Cash
52477000
Annuals > 3 > ratios > PE
-3.5900958690894025
Annuals > 3 > ratios > PB
9.282819332554599
Annuals > 3 > ratios > ROE
-76.59437218870951
Annuals > 3 > ratios > ROA
-43.29156333656326
Annuals > 3 > ratios > FCF
-132037000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-7.017272534013605
Annuals > 3 > health Score
22
Valuation > metrics > PE
-0.8987965780311853
Valuation > metrics > PB
21.757660644094774
Valuation > final Score
20
Valuation > verdict
625.3% Overvalued
Profitability > metrics > ROE
-41.723300475519906
Profitability > metrics > ROA
-26.16256005077922
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6805159288965081
Risk > metrics > Interest Coverage
-77.62368815592204
Risk > final Score
-262
Risk > verdict
High
Liquidity > metrics > Current Ratio
32.31687344913151
Liquidity > metrics > Quick Ratio
32.31687344913151
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-312
Prev Risks > 1
-110
Prev Risks > 2
-642
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:14:15.343Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.9
Earnings History > 0 > eps Estimate
-0.8458
Earnings History > 0 > eps Difference
-0.0542
Earnings History > 0 > surprise Percent
-6.4081
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.98
Earnings History > 1 > eps Estimate
-0.66
Earnings History > 1 > eps Difference
-0.32
Earnings History > 1 > surprise Percent
-48.4848
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.67
Earnings History > 2 > eps Estimate
-0.7076
Earnings History > 2 > eps Difference
0.0376
Earnings History > 2 > surprise Percent
5.3137
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-17
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.61
Earnings History > 3 > eps Estimate
-0.6288
Earnings History > 3 > eps Difference
0.0188
Earnings History > 3 > surprise Percent
2.9898
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.6644
Earnings History > 4 > eps Estimate
-0.6
Earnings History > 4 > eps Difference
-0.0644
Earnings History > 4 > surprise Percent
-10.7333
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.6
Earnings History > 5 > eps Estimate
-0.61
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
1.6393
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.59
Earnings History > 6 > eps Estimate
-0.51
Earnings History > 6 > eps Difference
-0.08
Earnings History > 6 > surprise Percent
-15.6863
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-19
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.5
Earnings History > 7 > eps Estimate
-0.49
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-2.0408
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.53
Earnings History > 8 > eps Estimate
-0.52
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-1.9231
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-09
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.47
Earnings History > 9 > eps Estimate
-0.56
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
16.0714
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.49
Earnings History > 10 > eps Estimate
-0.58
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
15.5172
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-07
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.46
Earnings History > 11 > eps Estimate
-0.57
Earnings History > 11 > eps Difference
0.11
Earnings History > 11 > surprise Percent
19.2982
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.55
Earnings History > 12 > eps Estimate
-0.69
Earnings History > 12 > eps Difference
0.14
Earnings History > 12 > surprise Percent
20.2899
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.06
Earnings History > 13 > eps Estimate
-1.04
Earnings History > 13 > eps Difference
-0.02
Earnings History > 13 > surprise Percent
-1.9231
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.21
Earnings History > 14 > eps Estimate
-0.62
Earnings History > 14 > eps Difference
0.41
Earnings History > 14 > surprise Percent
66.129
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-07
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.97
Earnings History > 15 > eps Estimate
-1.05
Earnings History > 15 > eps Difference
0.08
Earnings History > 15 > surprise Percent
7.619
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.02
Earnings History > 16 > eps Estimate
-0.85
Earnings History > 16 > eps Difference
-0.17
Earnings History > 16 > surprise Percent
-20
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-10
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.84
Earnings History > 17 > eps Estimate
-0.78
Earnings History > 17 > eps Difference
-0.06
Earnings History > 17 > surprise Percent
-7.6923
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.76
Earnings History > 18 > eps Estimate
-0.7
Earnings History > 18 > eps Difference
-0.06
Earnings History > 18 > surprise Percent
-8.5714
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-09
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.79
Earnings History > 19 > eps Estimate
-0.63
Earnings History > 19 > eps Difference
-0.16
Earnings History > 19 > surprise Percent
-25.3968
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.79
Earnings History > 20 > eps Estimate
-0.56
Earnings History > 20 > eps Difference
-0.23
Earnings History > 20 > surprise Percent
-41.0714
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-07
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.65
Earnings History > 21 > eps Estimate
-0.54
Earnings History > 21 > eps Difference
-0.11
Earnings History > 21 > surprise Percent
-20.3704
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.58
Earnings History > 22 > eps Estimate
-0.02
Earnings History > 22 > eps Difference
-0.56
Earnings History > 22 > surprise Percent
-2800
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.4
Earnings History > 23 > eps Estimate
-0.57
Earnings History > 23 > eps Difference
0.17
Earnings History > 23 > surprise Percent
29.8246
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.55
Earnings History > 24 > eps Estimate
-0.33
Earnings History > 24 > eps Difference
-0.22
Earnings History > 24 > surprise Percent
-66.6667
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.48
Earnings History > 25 > eps Estimate
-0.41
Earnings History > 25 > eps Difference
-0.07
Earnings History > 25 > surprise Percent
-17.0732
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-14
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.42
Earnings History > 26 > eps Estimate
-0.5
Earnings History > 26 > eps Difference
0.08
Earnings History > 26 > surprise Percent
16
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-18
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.43
Earnings History > 27 > eps Estimate
-0.5
Earnings History > 27 > eps Difference
0.07
Earnings History > 27 > surprise Percent
14
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-08
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.44
Earnings History > 28 > eps Estimate
-0.7
Earnings History > 28 > eps Difference
0.26
Earnings History > 28 > surprise Percent
37.1429
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-08
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.39
Earnings History > 29 > eps Estimate
-0.49
Earnings History > 29 > eps Difference
-0.9
Earnings History > 29 > surprise Percent
-183.6735
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-24
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-1.02
Earnings History > 30 > eps Estimate
-0.5
Earnings History > 30 > eps Difference
-0.52
Earnings History > 30 > surprise Percent
-104
Earnings History > 31 > period
2017-03-31
Earnings History > 31 > report Date
2017-05-04
Earnings History > 31 > date
2017-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.19
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.19
Earnings History > 31 > surprise Percent
-
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Read more →Bellevue Group AG Boosts Holdings in Scholar Rock Holding Corporation $SRRK MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$47.3333
Analyst Picks
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 122.93% of the total shares of Scholar Rock Holding Corp
1.
FMR Inc(14.3922%)
since
2025/06/30
2.
Siren, L.L.C.(9.6227%)
since
2025/06/30
3.
T. Rowe Price Associates, Inc.(9.1146%)
since
2025/06/30
4.
BlackRock Inc(6.9656%)
since
2025/06/30
5.
Samsara BioCapital, LLC(5.839%)
since
2025/06/30
6.
Fidelity Growth Compy Commingled Pl S(5.0587%)
since
2025/07/31
7.
Vanguard Group Inc(5.0575%)
since
2025/06/30
8.
Redmile Group, LLC(4.0873%)
since
2025/06/30
9.
US Small-Cap Growth II Equity Comp(3.7182%)
since
2025/06/30
10.
Fidelity Growth Company Fund(3.6209%)
since
2025/07/31
11.
T. Rowe Price New Horizons(3.4068%)
since
2025/07/31
12.
State Street Corp(3.1982%)
since
2025/06/30
13.
Bellevue Group AG(3.066%)
since
2025/06/30
14.
Eventide Asset Management, LLC(3.0306%)
since
2025/06/30
15.
Vanguard Total Stock Mkt Idx Inv(2.6789%)
since
2025/07/31
16.
BB Biotech AG Ord(2.5869%)
since
2024/12/31
17.
HHG PLC(2.549%)
since
2025/06/30
18.
Wellington Management Company LLP(2.1064%)
since
2025/06/30
19.
Hood River Capital Management LLC(2.0545%)
since
2025/06/30
20.
iShares Russell 2000 ETF(2.0374%)
since
2025/08/31
21.
T. Rowe Price Health Sciences(2.0224%)
since
2025/07/31
22.
Geode Capital Management, LLC(1.9634%)
since
2025/06/30
23.
Fairmount Funds Management LLC(1.8975%)
since
2025/06/30
24.
Marshall Wace Asset Management Ltd(1.7065%)
since
2025/06/30
25.
Fidelity Select Biotechnology(1.6984%)
since
2025/07/31
26.
Paradigm Biocapital Advisors LP(1.665%)
since
2025/06/30
27.
Vestal Point Capital LP(1.5604%)
since
2025/06/30
28.
Polar Capital Holdings PLC(1.5604%)
since
2025/06/30
29.
Polar Capital Biotech S Inc(1.5604%)
since
2025/07/31
30.
Eventide Gilead N(1.5198%)
since
2025/06/30
31.
COMMODORE CAPITAL LP(1.5084%)
since
2025/06/30
32.
Eventide Healthcare & Life Sciences I(1.4975%)
since
2025/06/30
33.
SPDR® S&P Biotech ETF(1.2681%)
since
2025/08/31
34.
T. Rowe Price New Horizons Tr-A(1.2117%)
since
2025/06/30
35.
American Funds SMALLCAP World A(1.1742%)
since
2025/06/30
36.
Fidelity Growth Company K6(1.1499%)
since
2025/07/31
37.
Hood River Small-Cap Growth Instl(1.1137%)
since
2025/06/30
38.
Fidelity Series Growth Company(0.9715%)
since
2025/07/31
39.
Fidelity Small Cap Index(0.8468%)
since
2025/06/30
40.
Vanguard Institutional Extnd Mkt Idx Tr(0.8379%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.9
EPS Estimate
-0.8458
EPS Difference
-0.0542
Surprise Percent
-6.4081%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.